ADIPOQ and fatty liver disease: The relationship between adiponectin concentration in the older population and their general condition, muscle mass, and the risk of mortality in this group of patients was investigated by Walowski et al. The results suggest that high levels of adiponectin are associated with lower muscle mass, reduced bone mineral content, and lower levels of fatty liver disease.